Diamond Edge Ventures — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
DigiLens develops waveguide optics and holographic display technology using a proprietary material set combined with inkjet printing and a holographic contact copy process.
Deep TechHardwareNew MaterialsSunnyvale, US
Jonathan Waldern(Director)inChristopher Pickett(Executive Officer, Director)Patrick Suel(Director)Robert Young(Director)Thorsten Alexander Kern(Director)
BoardJim Whims(Director)
Co-investorsAlsop Louie PartnersBold Capital PartnersDolby Family VenturesIn-Q-TelNautilus Ventures Management Company (Us), LlcSony Ventures Corporation+2 more
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Founder, Chief Executive Officer)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsALS Investment FundDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission Biocapital+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.











